Acutaas Chemicals Shares Jump 13% to a Record High After Q2 Profit Rises 71%, Up About 580% in 5 Years: Guidance, Valuation and Risks
- October 27, 2026
- Posted by: Ankit Jaiswal
- Category: News
Acutaas Chemicals shares closed at Rs 3,793.30 on the NSE on Tuesday, 27 Oct 2026, up 13.27% from Rs 3,348.80, after Q2 FY27 net profit rose 71.4% to Rs 123.1 crore and management raised FY27 guidance. Acutaas Chemicals shares touched a day high of Rs 3,900 on 4.75 million shares traded, and are up about 116% in 2026 as per Business Standard, while the Nifty 500 is down 9.4%.
Quick Answer
Acutaas Chemicals shares jumped about 13% to a record high because Q2 FY27 revenue rose 42.7% to Rs 436.9 crore, EBITDA rose 84.6% and net profit rose 71.4%, and management raised FY27 revenue growth guidance to about 30% from 25%. The EBITDA margin was 40.3% and the new South Korea plant for semiconductor-grade chemicals opened ahead of schedule. After the move Acutaas Chemicals shares trade near 71 times trailing earnings (my calculation) with an RSI of 73.6, which is overbought, so the news may already be in the price. This is educational and not a recommendation.
Acutaas Chemicals shares have risen about 580% in five years as per the headline, which makes the 13% jump on Q2 results a test of how much growth the market is already paying for. This article covers the Acutaas Chemicals Q2 results, the raised guidance, the South Korea plant, the valuation and the technical levels for Acutaas Chemicals shares, and the risks after such a sharp move.
I could not retrieve any brokerage rating or target for the stock this week, the order book or the capital spending figure, and the source figures for Q2 differ slightly, which I show side by side. An older Kotak Neo Muhurat list showed a target of Rs 1,780 for Acutaas Chemical, far below today’s price, and I could not verify its date. It is educational and not advice.
Click Here – Get Free Investment Predictions
Acutaas Chemicals Shares: What Happened on 27 Oct 2026
| Acutaas Chemicals shares: reference | Level | Meaning (my calculation) |
|---|---|---|
| Previous close, 26 Oct 2026 (NSE) | Rs 3,348.80 | Base for the 13% move |
| Open on 27 Oct | Rs 3,365.00 | Opened about 0.5% above the previous close |
| Day high (NSE) | Rs 3,900.00 | About 4.4% above the earlier record of Rs 3,735 from 6 Jul 2026 |
| Close (NSE), 27 Oct | Rs 3,793.30, up 13.27% | About 2.7% below the day high |
| Close (BSE), 27 Oct | Rs 3,794.55, up 13.34% | Volume on the NSE was about 47.5 lakh shares |
| Day low | Rs 3,360.50 | About 11.4% below the close |
Business Standard reported an intraday record of Rs 3,797 while the stock was still rising, and Acutaas Chemicals shares later went higher to Rs 3,900. The year-to-date gain of 116% compares with a fall of 9.4% in the Nifty 500, so Acutaas Chemicals shares have moved against the market in 2026.
Track Acutaas Chemicals shares and specialty chemicals stocks on Univest
Acutaas Chemicals Q2 Results: The Numbers
| Acutaas Chemicals shares: Q2 FY27 (Rs crore) | Business Standard | Data provider (Sep 2026 against Sep 2025) |
|---|---|---|
| Revenue | 436.9, up 42.7% | 442.02 against 316.04, up about 39.9% |
| EBITDA | 176.0, up 84.6% | 181.07 against 105.16, up about 72.2% |
| EBITDA margin | 40.3% against 31.1% | 41.44% against 34.34% |
| Net profit | 123.1, up 71.4% | 123.14 against 71.86, up about 71.4% |
| Gross margin | 62.1%, up 637 basis points | Not available |
Net profit matches in both sources, while revenue and EBITDA differ, probably because of what each includes in operating income. The provider lists the company under its earlier name, Ami Organics, and the Q2 profit of Rs 123.14 crore matches, so I read it as the same company (my reading). Pharmaceutical intermediates led growth and specialty chemicals were softer.
| Acutaas Chemicals shares: five quarters (data provider, Rs crore) | Revenue | EBITDA margin | Net profit |
|---|---|---|---|
| Sep 2025 | 316.04 | 34.34% | 71.86 |
| Dec 2025 | 397.88 | 39.51% | 106.22 |
| Mar 2026 | 443.86 | 44.97% | 134.28 |
| Jun 2026 | 331.47 | 34.84% | 74.99 |
| Sep 2026 | 442.02 | 41.44% | 123.14 |
Against the June 2026 quarter, revenue rose about 33% and profit about 64% (my calculation), which is a strong rebound. But Q2 profit is about 8% below the March 2026 quarter and the margin is below its March peak, so the business is lumpy from quarter to quarter and one strong quarter does not fix the trend.
Download the Univest iOS App or Univest Android App to set price alerts on Acutaas Chemicals shares and chemical stocks.
Guidance and Growth Drivers for Acutaas Chemicals Shares
| Acutaas Chemicals shares: driver | Detail from the reports | Why it matters |
|---|---|---|
| FY27 revenue guidance | Raised to about 30% growth from 25% | Management confidence in the order pipeline |
| FY27 EBITDA margin guidance | 38% to 40% | Q2 margin of 40.3% is already at the top of the range |
| South Korea plant | Inaugurated ahead of schedule; high-purity chemicals such as photoresists for semiconductor use | Opens a new, higher-value market |
| Semiconductor demand | Linked in one report to Tata Electronics and Micron projects in India | Possible long-term demand, not yet in the numbers |
| CDMO market | Indian market of USD 8.52 billion in 2025, projected at USD 16.53 billion by 2034 (company annual report) | About 7.6% a year (my calculation) |
Because the guidance for the EBITDA margin tops out at about the Q2 level, the guidance does not assume the margin keeps rising. The South Korea plant is the new leg of the story, but the reports give no revenue target for it and no capital spending figure, so its contribution cannot yet be sized. Investors comparing specialty chemicals stocks should look at margin, debt and order visibility together.
Valuation of Acutaas Chemicals Shares After the Jump
| Acutaas Chemicals shares: metric | Reading | Note |
|---|---|---|
| Market capitalisation | About Rs 31,000 crore at Rs 3,793.30 (my calculation) | Provider shows Rs 27,409 crore at the previous close |
| Trailing price to earnings | About 71 times (my calculation) | Provider shows 70.76 at the previous close using earnings that appear to exclude Q2 |
| Price to book | About 18.8 times (my calculation) | Book value Rs 201.97 per share |
| Return on equity | 21.54% | Provider figure |
| Debt to equity | 0.02 | Provider figure; almost debt free |
| Industry price to earnings | About 35.7 times | Stock trades at about twice the industry |
The provider’s trailing earnings per share of Rs 47.31 equals the sum of the four quarters ending June 2026, so it leaves out Q2. Adding Q2 raises trailing profit to about Rs 438.6 crore and earnings per share to about Rs 53.6 (my calculation using the implied share count), which gives about 71 times at the current Acutaas Chemicals share price. A third-party page shows five-year returns of about 570% and one-year returns of about 115%, but its price data are inconsistent, so I use it only as a rough cross-check.
Technical Levels for Acutaas Chemicals Shares
| Acutaas Chemicals shares: indicator (daily, 27 Oct) | Reading | Meaning |
|---|---|---|
| RSI (14) | 73.6 | Above 70 is overbought |
| 20-day EMA | Rs 3,254.84 | Price is about 16.6% above it (my calculation); stretched |
| Supertrend (10, 3) | Rs 3,098.33, trend up | Trend support; a close below it would flip the signal |
| Gap zone | Rs 3,348.80 to Rs 3,365 | Previous close and open; first support if the gain fades |
After a 13% one-day gain with an RSI above 70, a pause or pullback is common, and a pullback into the gap zone would not break the trend. These readings describe momentum and are not targets. Anyone trading the stock should decide a stop loss and position size before entering.
Risks to Acutaas Chemicals Shares
- Valuation. At about 71 times trailing earnings and about 18.8 times book value, Acutaas Chemicals shares already price in strong growth.
- Lumpy quarters. Profit fell in June 2026 and Q2 profit is below March 2026, so quarterly results can swing.
- Margin ceiling. Guidance of 38% to 40% leaves little room for a further rise in the EBITDA margin.
- New plant execution. The South Korea plant has no disclosed revenue target, and the semiconductor link is a long-term hope.
- Momentum reversal. Acutaas Chemicals shares, up 116% in 2026 with an RSI above 70, can fall sharply if growth slows.
Conclusion: Acutaas Chemicals Shares Have Strong Numbers and a Demanding Price
Acutaas Chemicals shares rose on a genuine beat: profit up 71%, EBITDA up 85% and guidance raised. The same move took the Acutaas Chemicals share price to about 71 times earnings, well above the record from July and well above its 20-day average. Read the company’s filing and the call transcript, compare the quarter with the March peak, compare it with other specialty chemicals stocks, and decide with your own risk profile and not the headline gain.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Acutaas Chemicals shares jump 13% today?
Ans. Acutaas Chemicals shares rose 13.27% to Rs 3,793.30 on the NSE on 27 Oct 2026 after Q2 FY27 net profit rose 71.4% to Rs 123.1 crore, revenue rose 42.7% to Rs 436.9 crore and management raised FY27 revenue guidance to about 30% from 25%.
What were the Acutaas Chemicals Q2 results?
Ans. Business Standard reported revenue of Rs 436.9 crore, EBITDA of Rs 176.0 crore with a margin of 40.3%, a gross margin of 62.1% and net profit of Rs 123.1 crore. A data provider shows revenue of Rs 442.02 crore and an EBITDA margin of 41.44%, so small differences exist.
What is the Acutaas Chemicals share price and record high?
Ans. The NSE close on 27 Oct 2026 was Rs 3,793.30, and the day high was Rs 3,900. The earlier record was Rs 3,735 on 6 Jul 2026. Prices change through the day, so check the live quote.
What is the FY27 guidance for Acutaas Chemicals?
Ans. Management raised FY27 revenue growth guidance to about 30% from 25% and guided to an EBITDA margin of 38% to 40%. Q2 margin of 40.3% is already at the top of that range.
Is Acutaas Chemicals overvalued after the rally?
Ans. Acutaas Chemicals shares trade near 71 times trailing earnings and about 18.8 times book value (my calculation), against an industry price to earnings of about 35.7 times. That is a premium, so the price depends on growth continuing. Valuation alone does not predict the price.
What do the technical indicators say?
Ans. On the daily chart the RSI is 73.6, which is overbought, and the price is about 16.6% above the 20-day EMA of Rs 3,254.84. The Supertrend is up with support at Rs 3,098.33. These are momentum readings and not targets.
What are the main risks of Acutaas Chemicals shares?
Ans. The main risks are the high valuation, quarter-to-quarter swings in profit, a margin that is already at the top of guidance, execution of the South Korea plant and a sharp pullback after a 13% gain.
Is this article investment advice?
Ans. No. It is educational and not a recommendation to buy or sell. Please check the figures against company filings and your own risk profile before you act on anything you read here.
